Part of Phaidon International
Part of Phaidon International
Showing 598 results
Sort by:
Senior Process EngineerSwindon Up to £76,000 + BenefitsAre you an experienced Process Engineer with a strong background in pharmaceutical manufacturing, aseptic processing, or GMP-regulated production environments?Are you looking for the next step in your engineering career in a stable, long-term opportunity within a growing pharmaceutical business...
Key ResponsibilitiesClinical Program LeadershipLead global and European clinical programs across a rare disease portfolio from planning through execution and study completion.Drive program delivery, ensuring alignment with broader clinical development and corporate objectives.Maintain oversight of timelines, budgets, quality metrics, risk manageme...
Rare Disease Account Manager for growing Pharmaceutical companyLocation: Remote (Boston Area Preferred) Territory: New England Salary: $130,000 - $150,000 + Quarterly Bonus + Excellent Benefits A rapidly growing specialty pharmaceutical company is seeking a Rare Disease Account Manager to support its expanding commercial presence across the New Eng...
Take the first step toward your next opportunity - submit your CV and get started today.
Director / Senior Director, Educational Strategy (CME/IME) EPM is partnering with a growing, nationally recognized healthcare education organization that's seeking a commercially driven Director or Senior Director, Educational Strategy to join its growing business development team. This individual will play a key role in expanding pharmaceutical an...
Publications ManagerEPM is partnering with an independent, award-winning global healthcare agency specializing in medical communications, market access, and HEOR. Due to continued demand from both new and existing biopharma clients, the agency is hiring a Publication Manager to join its Medical Communications team in the US! This is a highly visibl...
Cardiology Account Specialist | Philadelphia South Territory Join a first-in-class commercial team driving adoption of novel therapies at the intersection of cardiovascular and metabolic disease. This organization is redefining how complex, high-risk patient populations are identified, managed, and treated - partnering closely with specialists, hea...